1-3 of 3
Kai Lehmberg
Close
Sort by
Journal Articles

MAP kinase activating death domain deficiency is a novel cause of impaired lymphocyte cytotoxicity

Kerstin Schütze, Miriam Groß, Kerstin Cornils, Katharina Wustrau, Sonja Schneppenheim, Henning Lenhartz, G. Christoph Korenke, Gritta Janka, Svea Ledig, Ingo Müller, Stephan Ehl, Kai Lehmberg
Journal: Blood Advances
Blood Adv (2023) 7 (8): 1531–1535.
https://doi.org/10.1182/bloodadvances.2022008195
Published: 2023
Includes: Supplemental data
Journal Articles

Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study

Clinical Trials & Observations
Elisabet Bergsten, AnnaCarin Horne, Ida Hed Myrberg, Maurizio Aricó, Itziar Astigarraga, Eiichi Ishii, Gritta Janka, Stephan Ladisch, Kai Lehmberg, Kenneth L. McClain, Milen Minkov, Vasanta Nanduri, Diego A. Rosso, Elena Sieni, Jacek Winiarski, Jan-Inge Henter
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3754–3766.
https://doi.org/10.1182/bloodadvances.2020002101
Published: 2020
Includes: Supplemental data
Journal Articles

Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis

Clinical Trials & Observations
Matthias Felber, Colin G. Steward, Karim Kentouche, Anders Fasth, Robert F. Wynn, Ulrike Zeilhofer, Veronika Haunerdinger, Benjamin Volkmer, Seraina Prader, Bernd Gruhn, Stephan Ehl, Kai Lehmberg, Daniel Müller, Andrew R. Gennery, Michael H. Albert, Fabian Hauck, Kanchan Rao, Paul Veys, Moustapha Hassan, Arjan C. Lankester, Jana Pachlopnik Schmid, Mathias M. Hauri-Hohl, Tayfun Güngör
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1998–2010.
https://doi.org/10.1182/bloodadvances.2020001748
Published: 2020
Includes: Supplemental data